๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The role of Gemtuzumab Ozogamicin in the treatment of acute myeloid leukemia patients

โœ Scribed by Pagano, L; Fianchi, L; Caira, M; Rutella, S; Leone, G

Book ID
110072362
Publisher
Nature Publishing Group
Year
2007
Tongue
English
Weight
190 KB
Volume
26
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Gemtuzumab ozogamicin in the treatment o
Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia
โœ Francis Giles; Elihu Estey; Susan O'Brien ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 484 KB ๐Ÿ‘ 2 views

## Abstract Gemtuzumab ozogamicin (GO) is a chemotherapeutic agent that consists of a humanized antiโ€CD33 antibody (hP67.6) linked to Nโ€acetylโ€ฮณ calicheamicin 1,2โ€dimethyl hydrazine dichloride, a potent enediyne antitumor antibiotic. GO was approved conditionally by the Federal Drug Administration